4-methoxyamphetamine has been researched along with cardiovascular agents in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| GOLDSTONE, B | 1 |
| KARLEN, WS; KLAYMAN, MI; SILBERG, NR | 1 |
| OSSWALD, H; ROSSEL, W | 1 |
| Ioannidis, JP; Katritsis, DG | 1 |
| Fujiwara, H; Kawasaki, M; Minatoguchi, S; Nishigaki, K; Takemura, G; Tanihata, S | 1 |
| Aoyama, T; Ishii, H; Iwashima, S; Kasuga, H; Kawade, Y; Kawahara, H; Maruyama, S; Matsuo, S; Murohara, T; Takahashi, H; Toriyama, T; Yamada, S; Yasuda, K; Yuzawa, Y | 1 |
| Doig, C; Kutsogiannis, DJ; Pagliarello, G; Ross, H; Shemie, SD | 1 |
| Kapanadze, LG; Mareev, VIu; Nasonova, SN; Petrukhina, AA; Skvortsov, AA | 1 |
| Baek, SH; Chae, SC; Cho, HJ; Cho, MC; Choe, WS; Choi, DJ; Choi, JO; Hwang, KK; Jeon, ES; Kang, SM; Kim, H; Kim, JJ; Kim, KH; Kim, MS; Lee, HY; Lee, SE; Lim, NK; Oh, BH; Park, HY; Yoo, BS | 1 |
| Arroyo, D; Benamer, H; Champagne, S; Chevalier, B; Garot, P; Gautier, A; Hovasse, T; Lefèvre, T; Neylon, A; Sanguineti, F; Unterseeh, T | 1 |
| Bennett, J; Cutlip, DE; Doros, G; Garcia-Garcia, HM; Gharib, EG; Kandzari, DE; Koolen, JJ; Roguin, A; Waksman, R | 1 |
3 review(s) available for 4-methoxyamphetamine and cardiovascular agents
| Article | Year |
|---|---|
Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Bayes Theorem; Cardiovascular Agents; Coronary Artery Disease; Coronary Disease; Coronary Stenosis; Death; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome | 2005 |
Medical management to optimize donor organ potential: review of the literature.
Topics: Brain Death; Cardiovascular Agents; Critical Care; Death; Graft Survival; Hormones; Humans; Respiratory System Agents; Tissue and Organ Procurement | 2006 |
[The role of hypotension as a factor of unfavorable prognosis in patients with chronic heart failure].
Topics: Cardiovascular Agents; Cardiovascular System; Chronic Disease; Death; Heart Failure; Humans; Hypotension; Meta-Analysis as Topic; Organs at Risk; Prognosis; Risk Factors | 2011 |
1 trial(s) available for 4-methoxyamphetamine and cardiovascular agents
| Article | Year |
|---|---|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.
Topics: Absorbable Implants; Cardiovascular Agents; Coronary Artery Disease; Death; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Prosthesis Design; Sirolimus; Treatment Outcome | 2022 |
7 other study(ies) available for 4-methoxyamphetamine and cardiovascular agents
| Article | Year |
|---|---|
Death associated with methonium treatment.
Topics: Cardiovascular Agents; Death; Hypertension; Muscle Relaxants, Central | 1952 |
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics | 1953 |
[Effect of dehydrated ergot alkaloid on hypoglycemic convulsions and death].
Topics: Cardiovascular Agents; Death; Dehydration; Ergot Alkaloids; Hypoglycemia; Hypoglycemic Agents; Seizures | 1953 |
Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1.
Topics: Aged; Angina, Unstable; Cardiovascular Agents; Case-Control Studies; Coronary Artery Disease; Death; Female; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome | 2006 |
Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cohort Studies; Coronary Artery Disease; Coronary Stenosis; Death; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Renal Dialysis; Risk Factors; Survival Rate; Time Factors; Treatment Outcome | 2006 |
Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Topics: Adult; Aged; Blood Pressure; Cardiovascular Agents; Death; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Discharge; Patient Readmission; Predictive Value of Tests; Prognosis; Registries; Republic of Korea; Risk Assessment; Risk Factors; ROC Curve; Ventricular Function, Left | 2019 |
Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
Topics: Cardiovascular Agents; Death; Drug-Eluting Stents; Everolimus; Humans; Kaplan-Meier Estimate; Myocardial Infarction; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2022 |